Lamisil DermGel 10 mg/g gel
| Name | Lamisil DermGel 10 mg/g gel |
|---|---|
| Former Name | Lamisil DermGel 1% gel |
| Marketing Authorisation Number | HR-H-344287404 |
| Active Substance | terbinafin |
| Composition | 1 g gela sadrži 10 mg terbinafina |
| Pharmaceutical Form | gel |
| Manufacturer | GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, München, Njemačka Delpharm Huningue S.A.S., Huningue, Francuska |
| Marketing Authorisation Holder | Karo Healthcare AB, Box 16184, Stockholm, Švedska |
| Marketing Authorisation Date | 30.08.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/319 |
| Registration Number | 381-12-01/171-24-46 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for non-renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | D01AE15 |
| Marketing status | Not marketed |
| SmPC | download |
| PL | download |
